BioSpace News Archive

Business

Recipharm to End Operations at Two Swedish Facilities, 225 Employees Affected

The company will explore opportunity to close facilities during second half of 2019.

November 9, 2017
·
2 min read
·
Alex Keown
Job Trends

After $40M Financing, Exonics Therapeutics to Start Hiring for Cambridge Lab

The cash will allow the company to hire scientists to conduct preclinical research into a potential treatment for DMD.

November 9, 2017
·
2 min read
·
Mark Terry
Deals

Siemens to Replace Healthineers CFO in Preparation for Listing

The public listing is expected to value the business at around $46 billion.

November 9, 2017
·
2 min read
·
Alex Keown
Business

Leti Joins DARPA-Funded Consortium of Seeing and Hearing Foundation to Develop Implantable Device for Restoring Vision

Leti announced today that a team of its researchers is participating in a U.S.-funded project to develop a safe, implantable neural interface system to restore vision by stimulating the visual cortex.

November 9, 2017
·
4 min read
Drug Development

Anthera Pharmaceuticals Announces Completion of Recruitment in the Phase III RESULT Clinical Study of Sollpura

The RESULT study allows for more frequent and higher dose adjustments based upon clinical signs and symptoms than the previous Phase 3 SOLUTION study.

November 9, 2017
·
2 min read
Job Trends

Sangamo Inks Deal for New HQ in Bay Area Biotech Hub

Sangamo is moving its corporate headquarters to a new site at Oyster Point in Brisbane, CA.

November 9, 2017
·
2 min read
·
Mark Terry
FDA

How Sweet It Is: Dynavax Finally Wins FDA OK for Hep B Vaccine Heplisav

The FDA approved Dynavax’s Heplisav-B, it’s first new hepatitis B vaccine in the U.S. in more than 25 years.

November 9, 2017
·
2 min read
·
Mark Terry